Searchable abstracts of presentations at key conferences in endocrinology

ea0003p11 | Bone | BES2002

Effect of rosiglitazone on bone strength in osteoporotic rats

Oge A , Bayraktar F , Uyulgan B , Yilmaz C , Kabalak T

Objective: Thiazolidinediones offer promise as oral insulin-sensitizing agents. Peroxisome proliferator-activated receptor-g (PPARg), a member of the steroid receptor superfamily, play a pivotal role in the differentiation of adipocytic cells. Osteoblasts and adipocytes are derived from common bone marrow stromal cells that play crucial roles in the generation of osteoclasts. Activation of peroxisome proliferator-activated receptor-g (PPARg) induces adipogenic differentiation ...

ea0003p115 | Diabetes & Metabolism | BES2002

Atorvastatin decreases LDL oxidation in glucocorticoid excess state

Bayraktar F , Oge A , Ozgonul M , Ozgen A , Sozmen E , Yilmaz C

Objectives-Aim: Oxidized low-density lipoprotein (LDL) seems to play an important role in the etiology of atherosclerosis. They stumulate atherosclerosis. Glucocorticoids decrease LDL degradation and expression of LDL receptor. Morever insulin resistance in glucocorticoid excess state may contribute to LDL oxidation changes. The aim of this study was to investigate, the LDL oxidation in glucocorticoid excess state and the effect of atorvastatin on LDL oxidation.<p class="...

ea0003p174 | Growth and Development | BES2002

Growth hormone therapy decreases LDL oxidation in oestrogen deficiency

Bayraktar F , Oge A , Ozgonul M , Ozgen A , Sozmen E , Yilmaz C

Objectives-Aim: Oxidized low-density lipoprotein (LDL) seems to play an important role in the etiology of atherosclerosis. They stumulate atherosclerosis. Oestradiol and other oestrogens have been shown to be powerful antioxidants in vitro when they are added to ldl oxidation mixtures. Oestrogen deficiency states are increases LDL oxidation. The aim of this study is investigate the effect of growth hormone on LDL oxidation in estrogen deficiency.Materia...

ea0002p3 | Bone | SFE2001

GROWTH HORMONE INCREASES FEMORAL AND VERTEBRAL BONE STRENGTH IN OSTEOPOROTIC RATS

Bayraktar F , Oge A , Ozgen A , Uyulgan B , Kabalak T , Yilmaz C

Objective: Human growth hormone (hGH) stimulates bone formation and have been proposed as therapeutic agents for osteoporosis. We have examined the effects of hGH on femoral and vertebral bone strength in osteoporotic rats.Methods: Thirty-five Sprague-Dawley rats were assigned to study in three groups: (1) Normal rats (without ovariectomy and corticosteroid therapy) (2) Osteoporosis group: ovariectomized (OVX) or with glucocorticoid induced osteoporotic ...

ea0003p10 | Bone | BES2002

A comparative study of raloxifen and estrogen on bone strength and cholesterol levels in ovariectomized rats

Oge A , Bayraktar F , Sevin G , Uyulgan B , Yilmaz C , Kabalak T

Objective: Estrogen or raloxifen prevent estrogen deficiency-induced bone loss animals and humans. There is a medical need for agent with the positive effects of estrogen on bone and the cardiovascular system, but without the negative effects tissue. So, we investigated the effects of raloxifen on bone strength and cholesterol levels in osteoporotic rats and compared them with estrogen treatment.Methods: Thirty-one ovariectomized (OVX) Sprague-Dawney ra...

ea0002p2 | Bone | SFE2001

ATORVASTATIN INCREASES FEMORAL AND VERTEBRAL BONE STRENGTH IN OSTEOPOROTIC RATS

Bayraktar F , Oge A , Uyulgan B , Ozgen A , Sevin G , Kitapcioglu G , Yilmaz C

Objective: HMG Coenzyme A reductase inhibitors (statins) mainly decrease low-density lipoproteins (LDL) cholesterol but also have been found to have beneficial effects in the skeleton. The aim of this study was to examine atorvastatin effects in vivo on femoral and vertebral bone strength.Methods: An ovariectomized (OVX), a glucocorticoid induced osteoporotic (GIO) and an OVX plus GIO group of rat models were used to study the effects of atorvastatin. Sp...